Jungmee Kim, M.D.
Allergy Physician in La Mirada, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,017 in Allergy Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Jungmee Kim, M.D. reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 2,722 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 3K
- Part D claims, 2023
- 66%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Jungmee Kim, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jungmee Kim, M.D. sits
This provider among allergy physician peers
Across the 175 allergy physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jungmee Kim, M.D. writes more Part D claims than 91% of them and scores higher on MIPS quality than 22% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one allergy physician peer from a representative sample of 60; the gold marker is Jungmee Kim, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Jungmee Kim, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jungmee Kim, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Allergy Physician compares to other specialties among California providers
Allergy Physician ranks #215 among California's specialties (0% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Allergy Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Jungmee Kim, M.D.'s 2023 MIPS final score plotted against the Allergy Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Allergy Physician) - 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Allergy Physician US NPIs
75/100 MIPS final score - 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Allergy Physician.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Jungmee Kim, M.D. appears in the CMS NPPES registry as an Allergy Physician provider holding M.D. credentials at 15040 IMPERIAL HWY, La Mirada, CA, 90638, with a listed phone of (562) 902-1014. NPI 1669465225 was issued on 08/29/2005.
Medicare Part D records for calendar year 2023 show 2,722 prescription claims written by this provider, covering 291 Medicare beneficiaries and totaling roughly $1.6 million in drug spend, split 33% brand-name and 66% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Allergy Physician is a narrow specialty nationwide, with 1,017 enrolled providers across 50 states and an average of 755 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1669465225 |
|---|---|
| Specialty | Allergy Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 08/29/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Jungmee Kim, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1669465225 is the unique 10-digit identifier CMS uses to link Kim across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jungmee Kim, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.0K
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Jungmee Kim, M.D.. To verify Jungmee Kim, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
33% brand-name claims vs 66% generic, on 2,722 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 5,280
- Total Day Supply
- 154,088
- Brand vs Generic
- 33% brand / 66% generic
- Brand Drug Cost
- $1.5M
- Generic Drug Cost
- $61K
- Antibiotic Claims
- 73
Patient Demographics
- Average Patient Age
- 74.2 years
- Avg HCC Risk Score
- 1.08
- Gender Split
- 71% female / 29% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Jungmee Kim, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Montelukast Sodium
Montelukast Sodium
192 claims
- Losartan Potassium
Losartan Potassium
132 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
98 claims
- Dupixent Syringe
Dupixent Syringe
86 claims
- Xolair
Xolair
78 claims
- Levothyroxine Sodium 75
Levothyroxine Sodium
75 claims
- Atorvastatin Calcium 71
Atorvastatin Calcium
71 claims
- Trelegy Ellipta 70
Trelegy Ellipta
70 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 192 |
| Losartan Potassium | 132 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 98 |
| Dupixent Syringe Dupilumab | 86 |
| Xolair Omalizumab | 78 |
| Levothyroxine Sodium | 75 |
| Atorvastatin Calcium | 71 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 70 |
| Omeprazole | 64 |
| Amlodipine Besylate | 56 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy Physician Overview
How Jungmee Kim, M.D. fits within the Allergy Physician landscape nationally.
Jungmee Kim, M.D.'s 2,722 claims are above the specialty average of 755.
Nearby Allergy Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Kim.
Compare Allergy Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Allergy Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is Jungmee Kim, M.D.'s specialty? ▼
How much does Jungmee Kim, M.D. prescribe under Medicare Part D? ▼
What is Jungmee Kim, M.D.'s Medicare quality score? ▼
Where is Jungmee Kim, M.D. located? ▼
What is Jungmee Kim, M.D.'s NPI number? ▼
Does Jungmee Kim, M.D. prescribe more brand-name or generic drugs? ▼
How many Allergy Physician providers are there in the US? ▼
What drugs does Jungmee Kim, M.D. prescribe most often? ▼
Does Jungmee Kim, M.D. accept Medicare? ▼
How can I verify Jungmee Kim, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.